普罗波福尔诱导认知障碍的分子机制:抑制临界海马路的抑制
Xueyue Zhou1, Shasha Dong2, Yuhai Xu1
1Department of Anesthesiology, Air Force Medical Center, Beijing, China.
Journal of neurochemistry
|April 23, 2025
概括
普罗波麻醉通过破坏海马神经重塑来损害大脑功能. 这项研究揭示了propofol抑制HTR1A/GRIA2/PIK3R1通路,导致记忆力缺陷和认知功能障碍.
科学领域:
- 神经科学是一个神经科学.
- 麻醉学 麻醉学
- 分子生物学分子生物学
背景情况:
- 普罗波是一种广泛使用的麻醉剂,与术后认知功能障碍 (POCD) 相关.
- 波对海马神经重塑和认知功能的影响背后的分子机制尚未完全理解.
研究的目的:
- 阐明普罗波影响海马神经重塑并导致认知功能障碍的分子机制.
- 调查HTR1A/GRIA2/PIK3R1信号通路在醇诱导的认知障碍中的作用.
主要方法:
- 使用单细胞RNA测序 (scRNA-seq) 和高通量转录组分析.
- 在体外实验中评估了神经元活动,突触可塑性,亡和炎症.
- 在体内研究评估了小鼠的空间记忆和学习能力.
主要成果:
- 发现普罗波可以抑制 (5-基三胺受体1A/谷氨酸受体2/酸酸3-激酶调节子单元1) HTR1A/GRIA2/PIK3R1信号通路.
- 在体外,醇减少了相关因素的表达,神经元活动和突触可塑性,同时增加了亡和炎症.
- 用普罗波治疗的小鼠在空间记忆和学习方面表现出显著的损伤.
结论:
- 醇诱导的抑制HTR1A/GRIA2/PIK3R1通路有助于海马神经重塑缺陷和认知功能障碍.
- 这些发现提供了对麻醉药物的影响的见解,并为预防和治疗POCD提供了基础.
- 了解这些分子机制对于明智的麻醉剂临床使用至关重要.
相关概念视频
Role of Hippocampus in Memory
82
The hippocampus, a critical brain structure, plays an essential role in memory processing, particularly in the formation and retrieval of memory. This small, seahorse-shaped region is located within the medial temporal lobe, with one hippocampus in each brain hemisphere. Experimental studies involving lesions in the hippocampi of rats have demonstrated significant impairments in tasks such as object recognition and maze navigation, indicating the hippocampus involvement in both recognition and...
82
Parenteral Anesthetics: Overview
84
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
84
Long-term Depression
2.4K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.4K
Antiepileptic Drugs: GABAergic Pathway Potentiators
259
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
259
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
85
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
85


